3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
156
INDUSTRY
99
NIH
43
NETWORK
23
UNKNOWN
1
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
5
Esophageal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Small Cell Lung Carcinoma
2
Pathologic Complete Response
2
Fallopian Tube Neoplasms
2
Adenocarcinoma of Lung
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thymoma
1
Testicular Neoplasms
1
Recurrence
1
Ovarian Neoplasms
1
Non-squamous Cell Non-Small Cell Lung Cancer
1
Non-Squamous Non-Small Cell Lung Cancer
1
Nasopharyngeal Carcinoma
1
Lung Neoplasms
1
HER2 Positive Breast Cancer
1
Endometrial Neoplasms
1
EGFR Positive Non-small Cell Lung Cancer
1
Carcinoma, Ovarian Epithelial
1
Interventions
apatinib
3
pembrolizumab
2
Poly(ADP-ribose) Polymerase Inhibitors
2
Hyperthermic Intraperitoneal Chemotherapy
2
Bevacizumab
2
taxane
1
olaparib
1
lenvatinib
1
fludarabine
1
cediranib
1
Whole Genome Sequencing
1
Valproic Acid
1
Tranexamic Acid
1
Tai Ji
1
Surgical Procedures, Operative
1
Sequence Analysis, RNA
1
Saline Solution
1
Radiation
1
Qigong
1
Propranolol
1
Positron Emission Tomography Computed Tomography
1
Population Groups
1
Platinum
1
Paclitaxel
1
Neoadjuvant Therapy
1
Interleukin-2
1
Indocyanine Green
1
Immunohistochemistry
1
Hydralazine
1
Gene Expression
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Ovarian Neoplasms
×
Carboplatin
×
Clear all
NCT01654146
2012-07-31
ICON8
Medical Research Council
Phase 3
Unknown
1,485 enrolled